IL2 and neoplasm: Cytokine adjuvant immunotherapy strategies for neuroblastoma have been investigated clinically with both autologous and allogeneic neuroblastoma tumour cells transduced with IL-2 (Bowman L et al, 1998; Bowman LC et al, 1998).